Could the next big cure be resting at the bottom of the ocean? That just might be to case according to some recent news out of OHSU. From an OHSU press release: OHSU researchers, in partnership with scientists from several other institutions, have published two new research papers that signal how the next class of powerful medications may currently reside at the bottom of the ocean. In both cases, the researchers were focused on ocean-based … Read More
New research from OHSU’s Oregon National Primate Research Center suggests this theory: external factors may influence the timing of puberty, just might be true. The research, published this week by Nature Neuroscience, gained the attention of several news outlets including KGW-TV here in Portland. An excerpt from our press release: The paper explains how OHSU scientists are investigating the role of epigenetics in the control of puberty. Epigenetics refers to changes in gene activity linked … Read More
The Oregonian’s Joe Rojas posted an interesting blog item today about research efforts that don’t pan out. Here’s a link to the full post. Here’s an excerpt Placing wire mesh stents in brain arteries for stroke protection failed big time in the first randomized clinical trial, reported widely this week. Safety monitors halted the Wingspan stent trial in April after seeing more strokes and deaths among people randomly assigned to receive stents. You would never … Read More
Scientists and physicians at the Oregon Health & Science University Knight Cancer Institute recently found new clues that could help them figure out why drugs that target mutations in breast tumors won’t be effective in stamping out cancer in some patients. The study, published a study in the Annals of Surgical Oncology, sheds light on mutations found in stem cells that could be causing some breast cancers to develop and may be the reason the … Read More
Oregon Health & Science University Knight Cancer Institute researchers uncovered a gene that may be the key to helping kidney cancer patients who don’t respond to current therapies. This discovery could also provide a toolkit to identify patients who are most likely to benefit from drugs that block this gene from causing cancer cells to grow. The OHSU study, which was recently published in Science Translational Medicine, identified a gene called Src that helps certain kidney … Read More
Joe Gray, Ph.D., a lead scientist with the Oregon Health & Science University Knight Cancer Institute, was involved in two studies published this week that make strides in understanding cancer. One of the studies, published in the June 30 edition of Nature, is the first comprehensive catalog of the genetic aberrations responsible for an aggressive type of ovarian cancer that accounts for 70 percent of all ovarian cancer deaths. The catalog is the most expansive … Read More
